Apple showcased innovative new wellbeing options at its annual event, with a notable highlight being M.I.A.’s involvement as a prominent partner. The Blood Oxygen feature, introduced with the Collection 6 device, will not initially be available in the United States. The rest of the world will gain access to cutting-edge technology through the innovative new smartwatch.
The absence of a vital feature like blood oxygen monitoring is glaring, particularly given the company’s emphasis on wellness-focused wearables. The company’s collaboration with Masimo, a renowned medical technology firm, has yielded a notable exclusivity to their function. The controversy surrounding a feature prompted Apple to suspend its functionality on the Apple Watch Series 9 and Extreme 2 models towards the end of last year.
Apple hasn’t disclosed whether the feature’s removal was a hardware modification in Series 10 or simply disabled via software, akin to what occurred with Series 9. Will we learn more about its specifications when the smartwatch hits the market and teardown experts get to work? If it’s a hardware repair issue, Apple would have had to develop distinct models tailored to each region’s specific requirements.
Apple has been actively countering Masimo’s suit since its inception. Following a brief hiatus, Apple worked diligently to re-implement its vital ban in January.
On Monday, Apple unveiled a slew of new Health features in Collection 10, which will be available globally.
